Transcription factor 4 (TCF4) and schizophrenia: Integrating the animal and the human perspective

Cellular and Molecular Life Sciences

Volumn 71, Issue 15, 2014, Pages 2815-2835

  Quednow, Boris B ^a   Brzózka, Magdalena M ^b   Rossner, Moritz J ^b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Basic Helix Loop Helix protein; Cognition; Endophenotype; Mouse models; Neurodevelopment; Polymorphism; Schizophrenia; Transcription factor 4

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MICRORNA; MICRORNA 137; UNCLASSIFIED DRUG;

ALLELE; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; COGNITION; ENDOPHENOTYPE; ETHNICITY; GENE; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PITT HOPKINS SYNDROME; REVIEW; SCHIZOPHRENIA; SMOKING; SYMPTOMATOLOGY; TCF4 GENE;

ANIMALIA; MUS; RODENTIA;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BRAIN; COGNITION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 84904392316     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1553-4     Document Type: Review

References (208)

1. Massari ME, Murre C (2000) Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 20:429-440 (Pubitemid 30023084)
2. Murre C, Bain G, van Dijk MA et al (1994) Structure and function of helix-loop-helix proteins. Biochim Biophys Acta 1218:129-135 (Pubitemid 24206875)
3. Ferré-D'Amaré AR, Prendergast GC, Ziff EB, Burley SK (1993) Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363:38-45
4. Skinner MK, Rawls A, Wilson-Rawls J, Roalson EH (2010) Basic helix-loop-helix transcription factor gene family phylogenetics and nomenclature. Differentiation 80:1-8
5. Bertrand N, Castro DS, Guillemot F (2002) Proneural genes and the specification of neural cell types. Nat Rev Neurosci 3:517-530 (Pubitemid 135706662)
6. Jones S (2004) An overview of the basic helix-loop-helix proteins. Genome Biol 5:226
7. Jin T, Liu L (2008) The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 22:2383-2392
8. Ephrussi A, Church GM, Tonegawa S, Gilbert W (1985) B lineage - specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134-140 (Pubitemid 15154218)
9. De Masi F, Grove CA, Vedenko A et al (2011) Using a structural and logics systems approach to infer bHLH-DNA binding specificity determinants. Nucleic Acids Res 39:4553-4563
10. Sepp M, Kannike K, Eesmaa A et al (2011) Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5́ exon usage and splicing. PLoS ONE 6:e22138
11. Sepp M, Pruunsild P, Timmusk T (2012) Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet 21:2873-2888
12. Chiaramello A, Soosaar A, Neuman T, Zuber MX (1995) Differential expression and distinct DNA-binding specificity of ME1a and ME2 suggest a unique role during differentiation and neuronal plasticity. Brain Res Mol Brain Res 29:107-118
13. Soosaar A, Chiaramello A, Zuber MX, Neuman T (1994) Expression of basic-helix-loop-helix transcription factor ME2 during brain development and in the regions of neuronal plasticity in the adult brain. Brain Res Mol Brain Res 25:176-180 (Pubitemid 24223282)
14. Zhuang Y, Kim CG, Bartelmez S et al (1992) Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc Natl Acad Sci USA 89:12132-12136 (Pubitemid 23004799)
15. Zhuang Y, Barndt RJ, Pan L et al (1998) Functional replacement of the mouse E2A gene with a human HEB cDNA. Mol Cell Biol 18:3340-3349 (Pubitemid 28240506)
16. Caudy M, Vässin H, Brand M et al (1988) daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex. Cell 55:1061-1067
17. Krause M, Park M, Zhang JM et al (1997) A C. elegans E/ Daughterless bHLH protein marks neuronal but not striated muscle development. Development 124:2179-2189 (Pubitemid 27283239)
18. Portman DS, Emmons SW (2000) The basic helix-loop-helix transcription factors LIN-32 and HLH-2 function together in multiple steps of a C. elegans neuronal sublineage. Development 127:5415-5426 (Pubitemid 32049195)
19. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43:969-976
20. Xiang X, Zhuang X, Ju S et al (2011) miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 30:3440-3453
21. Li G, Luna C, Qiu J et al (2011) Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:2999-3007
22. Kwon E, Wang W, Tsai L-H (2013) Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry 18(11-12):23
23. Navarrete K, Pedroso I, De Jong S et al (2013) TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B 162:1-16
24. Aronheim A, Shiran R, Rosen A, Walker MD (1993) The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc Natl Acad Sci USA 90:8063-8067 (Pubitemid 23260855)
25. Quong MW, Massari ME, Zwart R, Murre C (1993) A new transcriptional- activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol Cell Biol 13:792-800 (Pubitemid 23040244)
26. Massari ME, Grant PA, Pray-Grant MG et al (1999) A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell 4:63-73 (Pubitemid 29386132)
27. Qiu Y, Sharma A, Stein R (1998) p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol Cell Biol 18:2957-2964 (Pubitemid 28183465)
28. Loe-Mie Y, Lepagnol-Bestel A-M, Maussion G et al (2010) SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum Mol Genet 19:2841-2857
29. Forrest MP, Waite AJ, Martin-Rendon E, Blake DJ (2013) Knockdown of human TCF4 affects multiple signaling pathways involved in cell survival, epithelial to mesenchymal transition and neuronal differentiation. PLoS ONE 8:e73169
30. Tamminga CA, Holcomb HH (2005) Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10:27-39 (Pubitemid 40139587)
31. Goldstein JM, Tsuang MT, Faraone SV (1989) Gender and schizophrenia: implications for understanding the heterogeneity of the illness. Psychiatry Res 28:243-253 (Pubitemid 19165765)
32. Faraone SV, Chen WJ, Goldstein JM, Tsuang MT (1994) Gender differences in age at onset of schizophrenia. Br J Psychiatry 164:625-629 (Pubitemid 24161260)
33. Bromet EJ, Fennig S (1999) Epidemiology and natural history of schizophrenia. Biol Psychiatry 46:871-881 (Pubitemid 29452978)
34. Insel TR (2010) Rethinking schizophrenia. Nature 468:187-193
35. Van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635-645
36. Holzman PS, Matthysse S (1990) The genetics of schizophrenia: a review. Psychol Sci 1:279-286
37. McGue M, Gottesman II (1991) The genetic epidemiology of schizophrenia and the design of linkage studies. Eur Arch Psychiatry Clin Neurosci 240:174-181
38. Harrison PJ, Owen MJ (2003) Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361:417-419 (Pubitemid 36164980)
39. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68 image 5
40. Ng MYM, Levinson DF, Faraone SV et al (2009) Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 14:774-785
41. Williams HJ, Moskvina V, Smith RL et al (2011) Association between TCF4 and schizophrenia does not exert its effect by common nonsynonymous variation or by influencing cis-acting regulation of mRNA expression in adult human brain. Am J Med Genet B 156B:781-784
42. Williams HJ, Owen MJ, O'Donovan MC (2009) Schizophrenia genetics: new insights from new approaches. Br Med Bull 91:61-74
43. Sullivan PF, Daly MJ, O'Donovan M (2012) Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13:537-551
44. Lee KW, Woon PS, Teo YY, Sim K (2012) Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? Neurosci Biobehav Rev 36:556-571
45. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(Pt 4):593-624
46. Harrison PJ (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174:151-162
47. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303-326 (Pubitemid 16073151)
48. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR (1991) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 48:625-632
49. Falkai P, Schneider-Axmann T, Honer WG (2000) Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol Psychiatry 47:937-943 (Pubitemid 30320738)
50. Harrison PJ, Eastwood SL (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11:508-519 (Pubitemid 33100372)
51. Honer WG, Young CE (2004) Presynaptic proteins and schizophrenia. Int Rev Neurobiol 59:175-199 (Pubitemid 39752415)
52. Lewis DA (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev 31:270-276
53. Reynolds GP, Beasley CL, Zhang ZJ (2002) Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J Neural Transm 109:881-889 (Pubitemid 34810780)
54. Bertolino A, Weinberger DR (1999) Proton magnetic resonance spectroscopy in schizophrenia. Eur J Radiol 30:132-141 (Pubitemid 29281714)
55. Nudmamud S, Reynolds LM, Reynolds GP (2003) N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study. Biol Psychiatry 53:1138-1141 (Pubitemid 36695089)
56. Weinberger DR, Berman KF, Suddath R, Torrey EF (1992) Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 149:890-897
57. Friston KJ, Frith CD (1995) Schizophrenia: a disconnection syndrome? Clin Neurosci 3:89-97
58. McGlashan TH, Hoffman RE (2000) Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57:637-648 (Pubitemid 30445855)
59. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24:479-486 (Pubitemid 32695360)
60. Frankle WG, Lerma J, Laruelle M (2003) The synaptic hypothesis of schizophrenia. Neuron 39:205-216 (Pubitemid 36897544)
61. Marenco S, Weinberger DR (2000) The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 12:501-527
62. Miyamoto S, LaMantia AS, Duncan GE et al (2003) Recent advances in the neurobiology of schizophrenia. Mol Interv 3:27-39
63. Murray RM, O'Callaghan E, Castle DJ, Lewis SW (1992) A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18:319-332
64. Maynard TM, Sikich L, Lieberman JA, LaMantia AS (2001) Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull 27:457-476 (Pubitemid 33081697)
65. Arnold SE (1999) Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev Psychopathol 11:439-456
66. Impagnatiello F, Guidotti AR, Pesold C et al (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95:15718-15723 (Pubitemid 29018766)
67. Guidotti A, Pesold C, Costa E (2000) New neurochemical markers for psychosis: a working hypothesis of their operation. Neurochem Res 25:1207-1218
68. Van Broeckhoven C, Verheyen G (1999) Report of the chromosome 18 workshop. Am J Med Genet 88:263-270 (Pubitemid 29269493)
69. Potash JB, DePaulo JR Jr (2000) Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disord 2:8-26
70. Lewis CM, Levinson DF, Wise LH et al (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48 (Pubitemid 36793778)
71. Segurado R, Detera-Wadleigh SD, Levinson DF et al (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 73:49-62 (Pubitemid 36793779)
72. Pickard BS, Malloy MP, Clark L et al (2005) Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18. Psychiatr Genet 15:37-44 (Pubitemid 40411569)
73. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S et al (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:984-994
74. Breschel TS, McInnis MG, Margolis RL et al (1997) A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Hum Mol Genet 6:1855-1863 (Pubitemid 27460360)
75. Del-Favero J, Gestel SV, Børglum AD et al (2002) European combined analysis of the CTG18.1 and the ERDA1 CAG/CTG repeats in bipolar disorder. Eur J Hum Genet 10:276-280 (Pubitemid 34662097)
76. Stefansson H, Ophoff RA, Steinberg S et al (2009) Common variants conferring risk of schizophrenia. Nature 460:744-747
77. Steinberg S, de Jong S, Irish Schizophrenia Genomics Consortium et al (2011) Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 20:4076-4081
78. Li T, Li Z, Chen P et al (2010) Common variants in major histocompatibility complex region and TCF4 gene are significantly associated with schizophrenia in Han Chinese. Biol Psychiatry 68:671-673
79. Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2 (2012) Genome-wide association study implicates HLA-C&z.ast;01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 72:620-628
80. Aberg KA, Liu Y, Bukszár J et al (2013) A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry 70:1-9
81. McClellan J, King M-C (2010) Genomic analysis of mental illness: a changing landscape. JAMA 303:2523-2524
82. Papiol S, Malzahn D, Kästner A et al (2011) Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Transl Psychiatry 1:e45
83. Wirgenes KV, Sønderby IE, Haukvik UK et al (2012) TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry 2:e112
84. Lennertz L, Quednow BB, Benninghoff J et al (2011) Impact of TCF4 on the genetics of schizophrenia. Eur Arch Psychiatry Clin Neurosci 261(Suppl 2):S161-S165
85. Bleuler E (1911) Dementia praecox oder die Gruppe der Schizophrenien. In: Aschaffenburg G (ed) Handbuch der Psychiatrie, Spezieller Teil, 4. Abteilung, 1. Hälfte. Deutike, Leipzig
86. Kraepelin E (1909) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte
87. Carlsson A (1995) Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 10(Suppl 3):21-28
88. Braff D, Stone C, Callaway E et al (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343 (Pubitemid 9016401)
89. Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
90. Nuechterlein KH, Dawson ME (1984) Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 10:160-203
91. Nuechterlein KH, Dawson ME, Green MF (1994) Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia. Acta Psychiatr Scand Suppl 384:71-79 (Pubitemid 24356891)
92. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645 (Pubitemid 41079594)
93. Braff DL, Light GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology 174:75-85 (Pubitemid 38925093)
94. Braff DL, Light GA, Swerdlow NR (2007) Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 61:1204-1207 (Pubitemid 46669461)
95. Cadenhead KS, Carasso BS, Swerdlow NR et al (1999) Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry 45:360-364 (Pubitemid 29100043)
96. Cadenhead KS, Light GA, Geyer MA, Braff DL (2000) Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry 157:55-59 (Pubitemid 30027421)
97. Cadenhead KS, Light GA, Shafer KM, Braff DL (2005) P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 57:1504-1509 (Pubitemid 40805379)
98. Clementz BA, Geyer MA, Braff DL (1997) P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry 41:1035-1044 (Pubitemid 27225991)
99. Clementz BA, Geyer MA, Braff DL (1998) Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 155:1691-1694 (Pubitemid 28547492)
100. Patterson JV, Hetrick WP, Boutros NN et al (2008) P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res 158:226-247
101. Anokhin AP, Golosheykin S, Heath AC (2007) Genetic and environmental influences on emotion-modulated startle reflex: a twin study. Psychophysiology 44:106-112 (Pubitemid 46110456)
102. Anokhin AP, Heath AC, Myers E et al (2003) Genetic influences on prepulse inhibition of startle reflex in humans. Neurosci Lett 353:45-48 (Pubitemid 37464616)
103. Anokhin AP, Vedeniapin AB, Heath AC et al (2007) Genetic and environmental influences on sensory gating of mid-latency auditory evoked responses: a twin study. Schizophr Res 89:312-319 (Pubitemid 44881286)
104. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R et al (2008) Sensory gating in schizophrenia: P50 and N100 gating in antip-sychotic- free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 64:376-384
105. Greenwood TA, Braff DL, Light GA et al (2007) Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 64:1242-1250 (Pubitemid 350074822)
106. Greenwood TA, Lazzeroni LC, Murray SS et al (2011) Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 168:930-946
107. Quednow BB, Frommann I, Berning J et al (2008) Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia. Biol Psychiatry 64:766-773
108. Csomor PA, Stadler RR, Feldon J et al (2008) Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497-512
109. Oranje B, Geyer MA, Bocker KBE et al (2006) Prepulse inhibition and P50 suppression: commonalities and dissociations. Psychiatry Res 143:147-158 (Pubitemid 44301523)
110. Schwarzkopf SB, Lamberti JS, Smith DA (1993) Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 33: 815-828 (Pubitemid 23234633)
111. Allen AJ, Griss ME, Folley BS et al (2009) Endophenotypes in schizophrenia: a selective review. Schizophr Res 109: 24-37
112. Brzózka MM, Radyushkin K, Wichert SP et al (2010) Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry 68:33-40
113. Quednow BB, Ettinger U, Mössner R et al (2011) The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci 31:6684-6691
114. Quednow BB, Brinkmeyer J, Mobascher A et al (2012) Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci USA 109:6271-6276
115. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490-1501 (Pubitemid 28512015)
116. Kumari V, Postma P (2005) Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29:1021-1034 (Pubitemid 41097398)
117. Korzyukov O, Pflieger ME, Wagner M et al (2007) Generators of the intracranial P50 response in auditory sensory gating. Neuroimage 35:814-826 (Pubitemid 46420427)
118. Bak N, Glenthoj BY, Rostrup E et al (2011) Source localization of sensory gating: a combined EG and fMRI study in healthy volunteers. Neuroimage 54:2711-2718
119. Brzózka MM, Rossner MJ (2013) Deficits in trace fear memory in a mouse model of the schizophrenia risk gene TCF4. Behav Brain Res 237:348-356
120. Rössler W, Hengartner MP, Angst J, Ajdacic-Gross V (2012) Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years. Addiction 107:1174-1184
121. Weiser M, Reichenberg A, Grotto I et al (2004) Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry 161:1219-1223 (Pubitemid 38859171)
122. Gur RE, Calkins ME, Gur RC et al (2007) The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophr Bull 33:49-68 (Pubitemid 46026259)
123. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426-445 (Pubitemid 28323862)
124. Cannon TD, Huttunen MO, Lonnqvist J et al (2000) The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet 67:369-382 (Pubitemid 30616742)
125. Van Erp TGM, Therman S, Pirkola T et al (2008) Verbal recall and recognition in twins discordant for schizophrenia. Psychiatry Res 159:271-280
126. Faraone SV, Seidman LJ, Kremen WS et al (2000) Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry 48:120-126 (Pubitemid 30618801)
127. Lennertz L, Rujescu D, Wagner M et al (2011) Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology 63:131-136
128. Zhu X, Gu H, Liu Z et al (2013) Associations between TCF4 gene polymorphism and cognitive functions in schizophrenia patients and healthy controls. Neuropsychopharmacology 38:683-689
129. Albanna A, Choudhry Z, Harvey P-O et al (2013) TCF4 gene polymorphism and cognitive performance in patients with first episode psychosis. Schizophr Res. doi:10.1016/j.schres.2013.10.038
130. Kochunov P, Charlesworth J, Winkler A et al (2013) Transcriptomics of cortical gray matter thickness decline during normal aging. Neuroimage 82:273-283
131. Kim S, Cho H, Lee D, Webster MJ (2012) Association between SNPs and gene expression in multiple regions of the human brain. Transl Psychiatry 2:e113
132. Forrest M, Chapman RM, Doyle AM et al (2012) Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Hum Mutat 33:1676-1686
133. De Pontual L, Mathieu Y, Golzio C et al (2009) Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 30:669-676
134. Sweatt JD (2013) Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. Exp Mol Med 45:e21
135. Zweier C, Peippo MM, Hoyer J et al (2007) Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80:994-1001 (Pubitemid 46668469)
136. Takano K, Lyons M, Moyes C et al (2010) Two percent of patients suspected of having Angelman syndrome have TCF4 mutations. Clin Genet 78:282-288
137. Van Balkom IDC, Vuijk PJ, Franssens M et al (2012) Development, cognition, and behaviour in Pitt-Hopkins syndrome. Dev Med Child Neurol 54:925-931
138. Talkowski ME, Rosenfeld JA, Blumenthal I et al (2012) Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149:525-537
139. Giurgea I, Missirian C, Cacciagli P et al (2008) TCF4 deletions in Pitt-Hopkins Syndrome. Hum Mutat 29:E242-E251
140. Marangi G, Ricciardi S, Orteschi D et al (2012) Proposal of a clinical score for the molecular test for Pitt-Hopkins syndrome. Am J Med Genet A 158A:1604-1611
141. Lehalle D, Williams C, Siu VM, Clayton-Smith J (2011) Fetal pads as a clue to the diagnosis of Pitt-Hopkins syndrome. Am J Med Genet A 155A:1685-1689
142. Losonczy MF, Song IS, Mohs RC et al (1986) Correlates of lateral ventricular size in chronic schizophrenia, I: behavioral and treatment response measures. Am J Psychiatry 143:976-981 (Pubitemid 16073945)
143. Peippo MM, Simola KOJ, Valanne LK et al (2006) Pitt-Hopkins syndrome in two patients and further definition of the phenotype. Clin Dysmorphol 15:47-54 (Pubitemid 44481235)
144. Neuman T, Keen A, Knapik E et al (1993) ME1 and GE1: basic helix-loop-helix transcription factors expressed at high levels in the developing nervous system and in morphogenetically active regions. Eur J Neurosci 5:311-318 (Pubitemid 23108585)
145. Uittenbogaard M, Chiaramello A (2000) Differential expression patterns of the basic helix-loop-helix transcription factors during aging of the murine brain. Neurosci Lett 280:95-98 (Pubitemid 30109141)
146. Ravanpay AC, Olson JM (2008) E protein dosage influences brain development more than family member identity. J Neurosci Res 86:1472-1481 (Pubitemid 351642441)
147. Ishibashi M, Moriyoshi K, Sasai Y et al (1994) Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J 13:1799-1805
148. Nakamura Y, Sakakibara S, Miyata T et al (2000) The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells. J Neurosci 20:283-293 (Pubitemid 30220516)
149. Ross SE, Greenberg ME, Stiles CD (2003) Basic helix-loophelix factors in cortical development. Neuron 39:13-25 (Pubitemid 36830945)
150. Brockschmidt A, Filippi A, Charbel Issa P et al (2011) Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model. Hum Genet 130:645-655
151. Flora A, Garcia JJ, Thaller C, Zoghbi HY (2007) The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors. Proc Natl Acad Sci USA 104:15382-15387 (Pubitemid 47502926)
152. Zhuang Y, Cheng P, Weintraub H (1996) B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol 16:2898-2905 (Pubitemid 26161295)
153. Bergqvist I, Eriksson M, Saarikettu J et al (2000) The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur J Immunol 30:2857-2863
154. Guella I, Sequeira A, Rollins B et al (2013) Analysis of miR- 137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res 47(9):1215-1221
155. Brennand KJ, Simone A, Jou J et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-225
156. Quintana J, Wong T, Ortiz-Portillo E et al (2004) Anterior cingulate dysfunction during choice anticipation in schizophrenia. Psychiatry Res 132:117-130 (Pubitemid 39643009)
157. Sigurdsson T, Stark KL, Karayiorgou M et al (2010) Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 464:763-767
158. Meyer-Lindenberg AS, Olsen RK, Kohn PD et al (2005) Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 62:379-386 (Pubitemid 40471687)
159. Wolf RC, Vasic N, Sambataro F et al (2009) Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33:1464-1473
160. Braff DL (2011) Gating in schizophrenia: from genes to cognition (to real world function?). Biol Psychiatry 69:395-396
161. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181-188 (Pubitemid 20058094)
162. Quednow BB, Kühn K-U, Beckmann K et al (2006) Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions. Biol Psychol 71:256-263
163. Guillemot F (2007) Spatial and temporal specification of neural fates by transcription factor codes. Development 134:3771-3780
164. Lin C-H, Hansen S, Wang Z et al (2005) The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proc Natl Acad Sci USA 102:14877-14882 (Pubitemid 41457149)
165. Corneliussen B, Holm M, Waltersson Y et al (1994) Calcium/ calmodulin inhibition of basic-helix-loop-helix transcription factor domains. Nature 368:760-764 (Pubitemid 24153419)
166. Hauser J, Sveshnikova N, Wallenius A et al (2008) B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. Proc Natl Acad Sci USA 105:1267-1272 (Pubitemid 351397042)
167. Hauser J, Saarikettu J, Grundström T (2008) Calcium regulation of myogenesis by differential calmodulin inhibition of basic helix-loop-helix transcription factors. Mol Biol Cell 19:2509-2519
168. Onions J, Hermann S, Grundström T (1997) Basic helix-loophelix protein sequences determining differential inhibition by calmodulin and S-100 proteins. J Biol Chem 272:23930-23937 (Pubitemid 27410975)
169. Saarikettu J, Sveshnikova N, Grundström T (2004) Calcium/ calmodulin inhibition of transcriptional activity of E-proteins by prevention of their binding to DNA. J Biol Chem 279:41004-41011 (Pubitemid 39287701)
170. Bading H (2013) Nuclear calcium signalling in the regulation of brain function. Nat Rev Neurosci 14:593-608
171. Greer PL, Greenberg ME (2008) From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59:846-860
172. Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller JW, Craddock N et al (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371-1379
173. Ferreira MAR, O'Donovan MC, Meng YA et al (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:1056-1058
174. Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43:977-983
175. Green EK, Grozeva D, Jones I et al (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol Psychiatry 15:1016-1022
176. Thimm M, Kircher T, Kellermann T et al (2011) Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol Med 41:1551-1561
177. Erk S, Meyer-Lindenberg A, Schnell K et al (2010) Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiatry 67:803-811
178. Gomez-Ospina N, Tsuruta F, Barreto-Chang O et al (2006) The C terminus of the L-type voltage-gated calcium channel CaV1.2 encodes a transcription factor. Cell 127:591-606 (Pubitemid 44647432)
179. Aizawa H, Hu S-C, Bobb K et al (2004) Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science 303:197-202 (Pubitemid 38057563)
180. Gaudillière B, Konishi Y, de la Iglesia N et al (2004) A CaM-KII- NeuroD signaling pathway specifies dendritic morphogenesis. Neuron 41:229-241
181. Ince-Dunn G, Hall BJ, Hu S-C et al (2006) Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron 49:683-695 (Pubitemid 43290128)
182. Wilke SA, Hall BJ, Antonios JK et al (2012) NeuroD2 regulates the development of hippocampal mossy fiber synapses. Neural Dev 7:9
183. Wright C, Turner JA, Calhoun VD, Perrone-Bizzozero N (2013) Potential impact of miR-137 and its targets in schizophrenia. Front Genet 4:58
184. Smrt RD, Szulwach KE, Pfeiffer RL et al (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28:1060-1070
185. Szulwach KE, Li X, Smrt RD et al (2010) Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 189:127-141
186. Berrettini W, Yuan X, Tozzi F et al (2008) Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13:368-373 (Pubitemid 351399826)
187. Bierut LJ, Stitzel JA, Wang JC et al (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165:1163-1171
188. Caporaso N, Gu F, Chatterjee N et al (2009) Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS ONE 4:e4653
189. Liu JZ, Tozzi F, Waterworth DM et al (2010) Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42:436-440
190. Saccone NL, Saccone SF, Hinrichs AL et al (2009) Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B 150B:453-466
191. Petrovsky N, Ettinger U, Kessler H et al (2013) The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. Psychopharmacology (Berl) 229(1):31-40
192. Winterer G, Mittelstrass K, Giegling I et al (2010) Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3- CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B 153B:1448-1458
193. Ohlrogge M, Doucet JR, Ryugo DK (2001) Projections of the pontine nuclei to the cochlear nucleus in rats. J Comp Neurol 436:290-303 (Pubitemid 32613620)
194. Winer JA (2006) Decoding the auditory corticofugal systems. Hear Res 212:1-8
195. Woolf NJ, Butcher LL (1989) Cholinergic systems in the rat brain: IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 23:519-540 (Pubitemid 20035317)
196. Erwin RJ, Buchwald JS (1987) Midlatency auditory evoked responses in the human and the cat model. Electroencephalogr Clin Neurophysiol Suppl 40:461-467
197. Fendt M, Li L, Yeomans JS (2001) Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology 156:216-224 (Pubitemid 32702214)
198. Harrison JB, Woolf NJ, Buchwald JS (1990) Cholinergic neurons of the feline pontomesencephalon. I. Essential role in "Wave A" generation. Brain Res 520:43-54 (Pubitemid 20220828)
199. Reese NB, Garcia-Rill E, Skinner RD (1995) Auditory input to the pedunculopontine nucleus: I. Evoked potentials. Brain Res Bull 37:257-264
200. Morley BJ (2005) Nicotinic cholinergic intercellular communication: implications for the developing auditory system. Hear Res 206:74-88
201. Alkondon M, Pereira EF, Almeida LE et al (2000) Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 39: 2726-2739
202. Picciotto MR, Caldarone BJ, Brunzell DH et al (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92:89-108 (Pubitemid 34251128)
203. Besson M, Granon S, Mameli-Engvall M et al (2007) Longterm effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci USA 104:8155-8160 (Pubitemid 47185891)
204. Breese CR, Lee MJ, Adams CE et al (2000) Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 23:351-364
205. Freedman R, Olincy A, Ross RG et al (2003) The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 5:155-161 (Pubitemid 38899215)
206. Satta R, Maloku E, Zhubi A et al (2008) Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci USA 105:16356-16361
207. Philibert RA, Beach SRH, Gunter TD et al (2010) The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet B 153B:619-628
208. Whalen S, Héron D, Gaillon T et al (2012) Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat 33:64-72